OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

2025-06-30-accounts

Charity registration number SC005379 (Scotland)

SHARP

ANNUAL REPORT AND UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 JUNE 2025

SHARP

LEGAL AND ADMINISTRATIVE INFORMATION

Trustees Dr M J MacLeod, Chair
Prof
DrRAWheater, Secretary
DrW Simpson, Treasurer
Prof
J George
Prof
T MacDonald
Dr S MacKenzie
Dr J Malo
Dr M Collister-Bartlett
Prof C Delles
Dr S Watkins
Dr L Philips,
Mr B Forbes
Prof
L Neubeck
Mr J Murray
ProfC Breen
DrACameron
Dr R Clarke
DrO Mordi
MsL Steel
P Welsh
ProfA Brady
Senior CharityAdministrator Miss V Kirkwood
Charity number (Scotland) $C005379
Principal address Division of Molecular& Clinical Medicine
Ninewells Hospital & Medical School
Mailbox 1
NinewellsAvenue
Dundee
DD1 9SY
Independent examiner Murray TaylorAudit Limited
10 Murray Lane
Montrose
Angus
DD10 8LF
Bankers The Royal Bank of Scotland
3 High Street
Dundee
DD19LY

SHARP

CONTENTS

Page
Chairman's statement 1-2
Trustees report 3-6
Independent examiner's report 7
Statement of financial activities 8
Statement offinancial position 9
Notestothefinancialstatements 10-16

SHARP CHAIRMAN'S STATEMENT FOR THE YEAR ENDED 30 JUNE 2025 eeee en ee

CHAIRMAN’S REPORT JULY 2024 TO JUNE 2025

Executive Committee

Prof. Mary Joan MacLeod followed Prof. Christian Delles as new Chair of SHARP. The new Vice Chair is Professor Isla Mackenzie. Dr Rebecca Wheater continues to serve as Secretary and Dr Bill Simpson serves as Treasurer. The Committee is supported by Victoria Kirkwood.

In the reporting period the Committee and the wider Board of Trustees met three times in addition to the Annual general Meeting in November 2024.

Newsletters and Membership Engagement

SHARP continues to benefit from regular newsletters that keep members up-to-date with ongoing and upcoming activities. The newsletters are drafted by Ms Kirkwood and approved by the Executive Committee. In the weeks before the Annual Meeting the frequency of newsletter increases to highlight key events at the Meeting and to introduce speakers and faculty in advance. This has been one of the reasons for the success of the 2024 Annual Meeting.

Research Sub-Group and Funding initiatives

During the reporting period the Executive Committee continued to monitor the progress of the two research awards that were grants to Dr Seenan and Moullaali in the previous reporting period. Interim reports have been received, approved by the Executive Committee and shared with the membership through the newsletter. Summer Studentships: five summer studentships were awarded for summer 2024, and the outputs presented at the 2024 Annual Meeting. Five were awarded for summer 2025, with all 5 students presenting at the 2025 Annual Meeting.

Annual Meeting 2024

The 2024 Meeting has been a huge success with positive feedback from delegates, faculty and exhibitors. The Meeting saw its flagship workshops on both days, covering topics such as ECG analysis and management of diabetes. Oral presentations included state-of-the art lectures as well as original presentations in the same session, bringing expert opinions and new investigators together to discuss topics such as hypertension, lipids, clots & bleeds, obesity & diabetes, and cardiac diseases.

A new initiative was a special programme for pupils of Perth Grammar School who worked hard to win an award from The Wood Foundation to support SHARP. In return they were invited to the meeting where they discussed aspects of cardiovascular disease, careers in science and enjoyed a session of CPR training facilitated by Mr John Ramsay. They also met with medical students to get an idea of a day in a student's life.

SHARP is most grateful to Mr Stuart Nimmo and Mr Graham Huband from the Courier who raised funds in memory of the premature death of their colleague Chris Ferguson. They attended the conference dinner and parts of the conference also on behalf of Mr Ferguson's family.

Annual Scientific Meeting 2025

The 2025 meeting was also held at Crieff Hydro. Approximately 120 delegates attended, with very positive feedback regarding the educational and scientific value of the meeting. The areas covered included renal disease, heart failure, blood pressure measurement, Scottish Government primary and secondary prevention strategies and small vessel disease. The Keynote speaker was Professor Adrian Brady who gave a very informative overview of the progress in management of heart disease over the past 40 years. This year's workshops covered echo reports, aspects of lipid management, primary prevention including lipids, blood pressure and diabetes.

Twenty-four pupils from Crieff High School attended a workshop held parallel to the meeting. The youth programme raised the student's awareness of high blood pressure; introduced them to simulation-based learning with cardiac scenarios from the emergency department and refreshed their basic life-support skills. We were very grateful for the support of Dr Sarah Partridge from the British and Irish Hypertension Society, Mr John Ramsay from University of Dundee and Dr Craig Ramsay, and Emergency Medicine Consultant from the University of Aberdeen. This successful programme will be repeated with the opportunity given to other schools in the future.

Le

SSS...

Ais

SHARP

CHAIRMAN'S STATEMENT (CONTINUED) FOR THE YEAR ENDED 30 JUNE 2025

Donations

During the reporting period, SHARP received a total of £6,624.21 in donations. We are deeply grateful for the generosity shown by individuals, organisations, and families who chose to support our work, often in memory of loved ones.

Dr M J MacLeod Chairman

{3th March 2026 Dated sccvsccssesicnris woes

32

SHARP

TRUSTEES REPORT FOR THE YEAR ENDED 30 JUNE 2025

The Trustees present their annual report and financial statements for the year ended 30 June 2025.

The financial statements have been prepared in accordance with the accounting policies set out in note 1 to the financial statements and comply with the charity's governing document, the Charities and Trustee Investment (Scotland) Act 2005, the Charities Accounts (Scotland) Regulations 2006 (as amended) and "Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102)" (effective 1 January 2019).

Objectives and activities

To promote the concept of prevention of cardiovascular diseases, in primary care, in hospital practice and in the community

and in furtherance thereof but not otherwise:

a. to bring together in conference representatives of voluntary organizations, government departments, statutory authorities and individuals (both medical and paramedical);

b. to promote and carry out research, surveys and investigations and publicize the useful results thereof,

c. to assist in the organization of exhibitions, meetings, lectures, classes, seminars and training courses and other educational activities

d. to collect and disseminate information on cardiovascular disorders by appropriate means.

Public benefit

The Trustees have paid due regard to guidance issued by the Office of the Scottish Charity Regulator and the Charity Commission in deciding what activities the charity should undertake.

Achievements and performance

Significant activities and achievements against objectives

The significant activities and achievements are all outlined in the Chairperson's report.

Financial review

The statement of Financial Activities shows that the charity has made a surplus of £137,749. The aim of the charity is to break even each year. However this year the conference costs outstripped the associated income but a very welcome £155,950 legacy was received in the year. At 30 June 2025, the charity held unrestricted funds of £395,745.

Reserves policy

Policy on reserves

The trustees have established a policy whereby the funds not committed should be between 3 to 6 months of the resources expended.

Major risks

The Trustees have assessed the major risks to which the charity is exposed, and are satisfied that systems are in place to mitigate exposure to the major risks.

-3-

SHARP

TRUSTEES REPORT (CONTINUED) FOR THE YEAR ENDED 30 JUNE 2025

Major risk and management of those risks

The Executive Committee has assessed the major risks to which the charity is exposed, in particular those related to the operations and finances of the charity, and is satisfied that systems are in place to mitigate the charity's exposure to the major risks.

Financial instruments

Objectives and policies

The Charity’s activities expose it to a number of financial risks including credit risk, cash flow risk and liquidity risk. The use of financial derivatives is governed by the charity's policies approved by the board of trustees, which provide written principles on the use of financial derivatives to manage these risks. The charity does not use derivative financial instruments for speculative purposes.

Cash flow risk

The Charity’s activities expose it primarily to the financial risks of changes in interest rates. Interest bearing assets and liabilities are held at fixed rate to ensure certainty of cash flows.

Credit risk

The Charity’s principal financial assets are bank balances and cash, trade and other receivables, and investments. The Charity’s credit risk is primarily attributable to its trade receivables. The amounts presented in the balance sheet are net of allowances for doubtful receivables. An allowance for impairment is made where there is an identified loss event which, based on previous experience, is evidence of a reduction in the recoverability of the cash flows. The credit risk on liquid funds and derivative financial instruments is limited because the counterparties are banks with high credit-ratings assigned by international credit-rating agencies. The Charity has no significant concentration of credit risk, with exposure spread over a large number of counterparties and customers.

Plans for future periods

The trustees look forward to working closely with other organisations which share common objectives with SHARP and also to the Annual Scientific Meeting.

In addition to the annual scientific meeting regional meetings continue to be encouraged. These regional meetings supported by educational grants from a number of pharmaceutical companies have also not been easy to organise and companies continue to rationalise their activity to comply with the new code. The trustees continue to encourage SHARP members to consider arranging further local meetings not only for their educational value, but also to raise awareness of SHARP throughout Scotland and to encourage new membership. Advice on how to access financial support for these meetings is available from the SHARP office.

In addition to the above, the charity also intends to secure their long-term future by encouraging new, younger individuals to become members, and possibly trustees in the future.

The Trustees of SHARP remain committed to the on-going success of the organisation and increasing our activity in the promotion of good practice and awareness of all aspects of cardiovascular disease prevention and treatment.

-4-

SHARP

TRUSTEES REPORT (CONTINUED) FOR THE YEAR ENDED 30 JUNE 2025

Structure, governance and management

Nature of governing document

The charity was created by a Constitution dated 13 September 1988.

The charity is administered by an Executive Committee; members of the Executive Committee are elected by the trustees. No officer with the exception of Treasurer shall hold office for more than four consecutive years.

The Trustees who served during the year and up to the date of signature of the financial statements were: Dr M J MacLeod, Chair

==> picture [330 x 298] intentionally omitted <==

----- Start of picture text -----
|||||||| |---|---|---|---|---|---|---| |Prof|||MacKenzie,|Vice|Chair| |Dr|RA Wheater,|Secretary| |Dr W|Simpson,|Treasurer| |Prof|J|George| |Prof T|MacDonald| |Dr|S|MacKenzie| |Dr|S|Hutcheon|(Resigned|30|June|2025)| |Dr|J|Malo| |Dr|M|Collister-Bartlett| |Prof|C|Delles| |Mr|P|Forsyth|(Resigned|30|June|2025)| |Dr T|Quinn|(Resigned|30|June|2025)| |Dr|S|Watkins| |Dr|L|Philips,| |Mr|B|Forbes| |Prof|L|Neubeck| |Mr|J|Murray| |Prof C|Breen|(Appointed|1|April|2025)| |DrACameron|(Appointed|1|April|2025)| |Dr R|Clarke|(Appointed|9|June|2025)| |Dr O|Mordi|(Appointed|1|April|2025)| |MsL|Steel|(Appointed|1|April|2025)| |P|Welsh|(Appointed|1|April|2025)| |ProfA Brady|

----- End of picture text -----

Recruitment and appointment of trustees

The Trustees may, at any time, appoint any member to be a Trustee and those Trustees will be ratified at the following AGM.

The Trustees may at any time appoint any Trustee either on the basis that they have specialist experience and/or skills which could be of assistance to the charity.

The charity recruits Trustees as required using a mix of open recruitment and links within the communities it serves. Aregular skills audit is undertaken to identify any gaps within the Board which also informs recruitment.

None of the Trustees has any beneficial interest in the company. All of the Trustees are members of the company and guarantee to contribute £1 in the event of a winding up.

-5-

SHARP

TRUSTEES REPORT (CONTINUED) FOR THE YEAR ENDED 30 JUNE 2025

Organisational structure

The Executive Committee meets on a regular basis to assess grant applications and deal with the strategy of the charity. The day to day administration is carried out by the Business Administrator and Assistant Business Administrator.

The Executive Committee at the date of this report are shown on page 1.

The Trustees report was approved by the Board of Trustees.

Dr W Simpson, Treasurer Trustee

23 February 2026

-6-

SHARP

INDEPENDENT EXAMINER'S REPORT TO THE TRUSTEES OF SHARP eee

| report on the financial statements of the charity for the year ended 30 June 2025, which are set out on pages 8 to 16.

Respective responsibilities of Trustees and examiner

The charity's Trustees are responsible for the preparation of the financial statements in accordance with the terms of the Charities and Trustee Investments (Scotland) Act 2005 and the Charities Accounts (Scotland) Regulations 2006. The charity's Trustees consider that the audit requirement of Regulation 10(1)(a) to (c) of the 2006 Accounts Regulations does not apply. It is my responsibility to examine the financial statements as required under section 44(1)(c) of the Act and to state whether particular matters have come to my attention.

Basis of independent examiner's statement

My examination is carried out in accordance with Regulation 11 of the Charities Accounts (Scotland) Regulations 2006. An examination includes a review of the accounting records kept by the charity and a comparison of the financial statements presented with those records. It also includes consideration of any unusual items or disclosures in the financial statements, and seeking explanations from the trustees concerning any such matters. The procedures undertaken do not provide all the evidence that would be required in an audit and consequently | do not express an audit opinion on the view given by the financial statements.

Independent examiner's statement

Your attention is drawn to the fact that the charity has prepared financial statements in accordance with Accounting and reporting by Charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) in preference to the Accounting and Reporting by Charities: Statement of Recommended Practice issued on 1 April 2005 which is referred to in the extant regulations but has now been withdrawn. | understand that this has been done in order for the financial statements to provide a true and fair view in accordance with Generally Accepted Accounting Practice effective for reporting periods beginning on or after 1 January 2015.

In connection with my examination, no other matter except that referred to in the previous paragraph has come to my attention:

R Sim F.C.C.A.

Murray Taylor Audit Limited

Chartered Certified Accountants

10 Murray Lane Montrose

Angus DD10 8LF

Dated: 23 February 2026

a7 @

SHARP

STATEMENT OF FINANCIAL ACTIVITIES INCLUDING INCOME AND EXPENDITURE ACCOUNT

FOR THE YEAR ENDED 30 JUNE 2025

Unrestricted Unrestricted
funds funds
2025 2024
Notes £ £
Income from:
Donations and legacies 3 163,395 17,996
Charitable activities 4 38,129 17,599
Investments 5 4,372 4,557
Total income 205,896 40,152
Expenditure on:
Charitable activities 7 68,147 80,031
Total expenditure 68,147 80,031
Net income/(expenditure) and movement in funds 137,749 (39,879)
Reconciliation offunds:
Fund balances at 1 July2024 257,996 297 875
Fundbalancesat30June2025 395,745 257,996

The statement of financial activities includes all gains and losses recognised in the year. All income and expenditure derive from continuing activities.

-8-

SHARP

STATEMENT OF FINANCIAL POSITION AS AT 30 JUNE 2025

2025 2024
Notes £ £ £ £
Fixed assets
Property, plant and equipment 13 3 3
Current assets
Trade and other receivables 14 5,021 6,041
Cash at bank and in hand 391,712 252,972
396,733 259,013
Current liabilities 15 (991) (1,020)
Net current assets 395,742 257,993
Total assets less current liabilities 395,745 257,996
The funds ofthe charity
Unrestricted funds 16 395,745 257,996
395,745 257,996

The financial statements were approved by the Trustees on 23 February 2026

Dr W Simpson, Treasurer Trustee

-9-

SHARP

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 JUNE 2025

Charity information

SHARP is an unincorporated charity situated in Scotland..

The financial statements have been prepared in accordance with the charity's constitution, the Charities and Trustee Investment (Scotland) Act 2005, the Charities Accounts (Scotland) Regulations 2006 (as amended) and “Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102)” (as amended for accounting periods commencing from 1 January 2016). The charity is a Public Benefit Entity as defined by FRS 102.

The charity has taken advantage of the provisions in the SORP for charities applying FRS 102 Update Bulletin 1 not to prepare a Statement of Cash Flows.

The financial statements are prepared in sterling, which is the functional currency of the charity. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

At the time of approving the financial statements, the Trustees have a reasonable expectation that the charity has adequate resources to continue in operational existence for the foreseeable future. Thus the Trustees continue to adopt the going concern basis of accounting in preparing the financial statements.

1.3. Charitable funds Unrestricted funds are available for use at the discretion of the Trustees in furtherance of their charitable objectives.

Restricted funds are subject to specific conditions by donors or grantors as to how they may be used. The purposes and uses of the restricted funds are set out in the notes to the financial statements.

Endowment funds are subject to specific conditions by donors that the capital must be maintained by the charity.

Income is recognised when the charity is legally entitled to it after any performance conditions have been met, the amounts can be measured reliably, and it is probable that income will be received.

Cash donations are recognised on receipt. Other donations are recognised once the charity has been notified of the donation, unless performance conditions require deferral of the amount. Income tax recoverable in relation to donations received under Gift Aid or deeds of covenant is recognised at the time of the donation.

Legacies are recognised on receipt or otherwise if the charity has been notified of an impending distribution, the amount is known, and receipt is expected. If the amount is not known, the legacy is treated as a contingent asset.

-10-

SHARP

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 30 JUNE 2025

1 Accounting policies

(Continued)

1.5 Expenditure All expenditure is recognised once there is a legal or constructive obligation to that expenditure, it is probable settlement is required and the amount can be measured reliably. All costs are allocated to the applicable expenditure heading that aggregate similar costs to that category. Where costs cannot be directly attributed to particular headings they have been allocated on a basis consistent with the use of resources, with central staff costs allocated on the basis of time spent, and depreciation charges allocated on the portion of the asset's use. Other support costs are allocated based on the spread of staff costs.

1.6 Property, plant and equipment Property, plant and equipment are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Printer & scanner 33% reducing balance Computer 33% reducing balance Computer equipment 33% reducing balance

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is recognised in the statement of financial activities.

1.7 Impairment of non-current assets

At each reporting end date, the charity reviews the carrying amounts of its tangible assets to determine whether there is any indication that those assets have suffered an impairment loss. !f any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any).

Cash and cash equivalents include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.9 Financial instruments

The charity has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments. Financial instruments are recognised in the charity's balance sheet when the charity becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include trade and other receivables and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

-11-

SHARP NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 30 JUNE 2025

(Continued)

Basic financial liabilities

Basic financial liabilities, including trade and other payables and bank loans are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

Trade payables are obligations to pay for goods or services that have been acquired in the ordinary course of operations from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade payables are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

Derecognition of financial liabilities

Financial liabilities are derecognised when the charity's contractual obligations expire or are discharged or cancelled.

1.10 Employee benefits

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

Termination benefits are recognised immediately as an expense when the charity is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

2 Critical accounting estimates and judgements

In the application of the charity's accounting policies, the Trustees are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

3 Income from donations and legacies

Unrestricted Unrestricted
funds funds
2025 2024
£ £
Donations and gifts 163,045 17,546
Membership fees 350 450
163,395 17,996

-12-

SHARP

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 30 JUNE 2025

4 Income from charitable activities

Unrestricted Unrestricted
funds funds
2025 2024
£ £
Unrestricted funds
Conference income 38,129 17,599
5 Income from investments
Unrestricted Unrestricted
funds funds
2025 2024
£ £
Interest receivable 4,372 4,557
6 Grants payable
Unrestricted Unrestricted
funds funds
2025 2024
£ £
Grantstoindividuals 6,300 43,010

-13-

SHARP

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 30 JUNE 2025

7 Expenditure on charitable activities

Unrestricted Unrestricted
funds funds
2025 2024
£ £
Direct costs
Conference costs 43,536 15,510
Website cosis 3,020 333
Administrator costs 14,331 20,158
60,887 36,001
Grant funding of activities (see note 6) 6,300 43,010
Share ofsupport and governance costs (see note 9)
Governance 960 1,020
68,147 80,031
Analysis by fund
Unrestricted funds 68,147 80,031
8 Net movement in funds 2025 2024
£ E
The net movement in funds is stated after charging/(crediting):
Fees payable for the independent examination of the charity's financial
statements 960 1,020
9 Support costs allocated to activities
Total Total
2025 2024
£ £
Governance 990 1,020
2025 2024
Governance costs comprise: £ £
Independent examination fees 990 1,020
990 1,020

10 Trustees

During the year no trustee received a salary. (2024 - NIL)

-14-

SHARP

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 30 JUNE 2025

11. Employees

The average monthly number of employees during the year was:

Total

2025 2024 Number Number - -

There were no employees whose annual remuneration was more than £60,000.

12 Taxation

The charity is exempt from taxation on its activities because all its income is applied for charitable purposes.

13 Property, plant and equipment

13 Property, plant and equipment
Printer& Computer Computer Total
scanner equipment
£ £ £ £
Cost
At 1 July 2024 1,521 1,446 1,835 4,802
At 30 June 2025 1,521 1,446 1,835 4,802
Depreciation and impairment
At 1 July 2024 1,520 1,445 1,834 4,799
At 30 June 2025 1,520 1,445 1,834 4,799
Carrying amount
At 30 June 2025 1 1 1 3
At 30 June 2024 1 1 4 3
14 Trade and other receivables
2025 2024
Amounts falling due within one year: £ £
Prepayments and accrued income 5,021 6,041
15 Current liabilities
2025 2024
£ £
Accrualsanddeferredincome 991 1,020

-15-

SHARP

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 30 JUNE 2025

16 Unrestricted funds

At 1 July 2024 Incoming Resources At 30 June
resources expended 2025
£ £ £ £
Scottish Lipid funds 10,845 - - 10,845
Unrestricted designated funds 247,151 205,896 (68,147) 384,900
257,996 205,896 (68,147) 395,745
Previous year: At 1 July2023 Incoming Resources At 30 June
resources expended 2024
£ £ £ £
Scottish Lipid funds 10,845 - - 10,845
General funds 287,030 40,152 (80,031) 247,151
297,875 40,152 (80,031) 257,996

17 Related party transactions

There were no disclosable related party transactions during the year (2024 - none).

-16-